Atlas Trials

Efficacy, Safety, and Dose-response of a Live Biotherapeutic Product in Women With Acute Vaginal Infection

Clinical trial NCT06450990 · UNKNOWN

Trial details

NCT number
NCT06450990
Sponsor
NEXBIOME THERAPEUTICS
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Bacterial VaginosisVulvovaginal Candidiasis
Start date
2024-07-08
Primary completion
2025-12-28
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.